Table 5. List of Nanobubble medications under clinical trials and in market .
| Drug | Status | Application | Reference |
| Albunex | Marketed | Photoacoustic imaging | 174 |
| Perflutren lipid (Definity) | Marketed | ECG | 175 |
| Sonazoid | Marketed | US imaging | 176 |
| Sonovue | Marketed | US imaging | 177 |
| Lumason | Marketed | US imaging | 177 |
| MRX 815 | Phase II trials | Sonothrombolysis | 178 |
| RNS60 | Clinical trials | For treating Traumatic brain injury & amyotrophic lateral sclerosis | 179 |
| Doxorubicin | Marketed | Chemotherapy | 180 |
| Methotrexate | Marketed | Chemotherapy | 181 |
| Sorafenib | Marketed | Chemotherapy | 182 |
| Porphyrins chemical pigment | Marketed | Chemotherapy | 183 |
| Doxorubicin and Ciclosporin A | Marketed | Chemotherapy | 184 |
| Pemetrexed and Pazopanib | Marketed | Chemotherapy | 185 |
| Resveratrol | Marketed | Anticatabolic & cell apoptosis | 186 |
| Biotinylated anti-ErbB2 Affibody | Marketed | Inhibits overexpression of HER2 gene, ovarian cancer, lung cancer | 187 |
| Paclitaxel | Marketed | Treating prostate cancer | 188 |
| Vancomycin | Marketed | Antibiotic | 189 |
| Apomorphine | Marketed | Anti-Parkinson’s | 190 |